We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

ACC to Launch Valvular Heart Disease Program in China

By HospiMedica International staff writers
Posted on 08 Aug 2017
Print article
The American College of Cardiology (ACC; Washington, DC, USA), together with several prominent hospitals in central and eastern China, is debuting a series of educational forums on valvular heart disease prevention, diagnosis, and management. The forums are aimed at physicians, and will be delivered by valvular heart disease specialists from the ACC, who will join local Chinese speakers for lecture-style presentations and interactive discussions based on case studies.

The program will reach out to hundreds of health care professionals in Kunming, Yunnan Province; Wuhan, Hubei Province; and Fuzhou, Fujian Province and support their efforts to offer high-quality, readily accessible care for patients from underserved communities that may be at risk for developing valvular heart disease. In addition to the educational forums for clinicians, ACC presenters will be distributing patient education materials for each hospital to use with patients to ensure they have the latest information regarding risk factors and lifestyle modification strategies.

The trainings sessions, which are supported by the Edwards Lifesciences Foundation (Irvine, CA, USA) Every Heartbeat Matters initiative, will provide a comprehensive overview regarding common manifestations of valvular heart disease, with a focus on the latest updates regarding international guidelines-based patient care. The forums will also seek to improve coordination between different health care specialists who may treat patients with indications of valvular heart disease, including internists, general cardiologists, and cardiac surgeons.

“We are committed to working with our colleagues in China to implement this program in a way that achieves maximum impact for underserved patients in these areas, and furthers the ACC’s mission to prevent cardiovascular disease and improve patient care on a global scale,” said Mary Norine Walsh, MD, president of the ACC. “By directly working with clinicians where they live and practice, we are aiming to change the culture around treating and preventing heart disease in China.”

“We have identified China as one of our focus regions for ‘Every Heartbeat Matters’ because of the many underserved people suffering from heart valve disease in this country,” said Amanda Fowler, executive director of global corporate giving for Edwards Lifesciences Foundation. “By partnering with the ACC to provide expert clinical education, we believe we can exponentially increase our impact on patients and build-up sustainable high-quality care for the people of this region.”

Related Links:
American College of Cardiology
Edwards Lifesciences Foundation

Print article

Channels

Critical Care

view channel
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

Barrett's esophagus (BE) is the benign and treatable precursor condition to esophageal adenocarcinomas (EAC) which is usually diagnosed at an advanced stage and is difficult to treat. Finding BE, a sign... Read more

Surgical Techniques

view channel
Image: Bio-glue enables near-instantaneous gelling, sealing and healing of injured tissue (Photo courtesy of Pexels)

Game-Changing ‘Bio-Glue’ Could End Use of Surgical Sutures and Staple

Tissue adhesive washout and detachment are major issues for medical practitioners and may prove fatal for patients, especially when the separation happens in vital organs like the lungs, liver and the heart.... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.